OMAHA, Neb.--(BUSINESS WIRE)--Transgenomic, Inc. (NASDAQ: TBIO), today announced it will host a business and financial update conference call on Wednesday, April, 15, 2015 at 5:00 PM EDT.
To participate in the call, dial 866-952-1907 from the U.S. and Canada or 785-424-1826 from international locations and enter conference ID: TRANS. The call can also be accessed through a link on the Transgenomic website, http://www.videonewswire.com/event.asp?id=101819.
A replay of the call will be available for two weeks beginning approximately two hours after the call’s conclusion until 11:59 PM ET, April 29, 2015. To access the replay, dial 800-839-1232 (domestic) or 402-220-0460 (international).
About Transgenomic, Inc.
Transgenomic, Inc. is a global biotechnology company advancing personalized medicine in cardiology, oncology, and inherited diseases through advanced diagnostic technologies, such as its revolutionary ICE COLD-PCRTM and its unique genetic tests provided through its Patient Testing business. The company also provides specialized clinical and research services to biopharmaceutical companies developing targeted therapies and sells equipment, reagents and other consumables for applications in molecular testing and cytogenetics. Transgenomic’s diagnostic technologies are designed to improve medical diagnoses and patient outcomes.